Spiritual Care or Psychotherapy for Non-Curative Cancers

This study is looking at whether adding spiritual care or psychotherapy to standard palliative care can help people with non-curative cancers live longer. You would receive either 24 one-on-one sessions with a chaplain (Chaplain-Provided Spiritual Care) or 24 one-on-one sessions with a psychotherapist and meditation instructor (Psychotherapy and Meditation Intervention). The study aims to see if either of these approaches improves overall survival (how long people live). To join, you must be at least 18 years old, have a confirmed metastatic cancer (cancer that has spread) that is not curable, and a life expectancy of one year or less. The current status of this study is unclear, and it plans to enroll 854 people.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 854 participants.
What's involved
Participants will receive 24 individual, one-on-one sessions with either a chaplain or a psychotherapist/meditation instructor.
Compensation
Not stated in the trial record.
Follow-up
Overall survival will be measured from the start of the intervention until the date of death, up to 30 days after completing the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07290491

Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies

Recruiting
PHASE3Ages 18+InterventionalTreatment
The Methodist Hospital Research Institute
~854 participants
Updated 2025-12-18 on ClinicalTrials.gov
What's tested:Chaplain-Provided Spiritual CarePsychotherapy and Meditation Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To determine the overall survival (OS) of patients with non-curative malignancies
Measured over From start of intervention till the date of death, up to 30 days after completing intervention
Cancer
1 sites across 1 states
Texas1
  • Hanh Mai, DO · PRINCIPAL_INVESTIGATOR · Houston Methodist Neal Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

The patient provides written informed consent for the trial.
Male or female ≥18 years of age on the day of informed consent signing.
Histologically confirmed metastatic disease with life expectancy of one year or less.
Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 3.
Willing and able to comply with the protocol for the duration of the trial including undergoing scheduled visits and interventions.

Exclusion

Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial. If a patient develops a psychiatric disorder after baseline, he/she will not be taken off the trial.
Mobility limitations that would interfere with cooperation with the requirements of the trial.
Confirmed positive pregnancy test in women of child bearing potential.
  • To determine the overall survival (OS) of patients with non-curative malignanciesFrom start of intervention till the date of death, up to 30 days after completing intervention

    To determine the overall survival (OS) of patients with non-curative malignancies who receive chaplain-provided spiritual care or psychotherapy/ meditation in addition to SOC and palliative measures, plus chemotherapy if recommended.